David Lowrance

2019

In 2019, David Lowrance earned a total compensation of $699K as Chief Financial Officer & Secretary at Mast Therapeutics, a 68% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$116,727
Option Awards$180,706
Salary$379,600
Other$22,000
Total$699,033

Lowrance received $379.6K in salary, accounting for 54% of the total pay in 2019.

Lowrance also received $116.7K in non-equity incentive plan, $180.7K in option awards and $22K in other compensation.

Rankings

In 2019, David Lowrance's compensation ranked 10,693rd out of 13,971 executives tracked by ExecPay. In other words, Lowrance earned more than 23.5% of executives.

ClassificationRankingPercentile
All
10,693
out of 13,971
24th
Division
Manufacturing
4,326
out of 5,701
24th
Major group
Chemicals And Allied Products
1,680
out of 2,200
24th
Industry group
Drugs
1,437
out of 1,886
24th
Industry
Pharmaceutical Preparations
1,064
out of 1,398
24th
Source: SEC filing on April 15, 2020.

Lowrance's colleagues

We found two more compensation records of executives who worked with David Lowrance at Mast Therapeutics in 2019.

2019

Robert Neville

Mast Therapeutics

Chief Executive Officer

2019

Taneli Jouhikainen

Mast Therapeutics

Chief Operating Officer

News

You may also like